These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16629639)

  • 21. Keeping promises: translating basic research into new spinal cord injury therapies.
    Kleitman N
    J Spinal Cord Med; 2004; 27(4):311-8. PubMed ID: 15484661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-based transplantation strategies to promote plasticity following spinal cord injury.
    Ruff CA; Wilcox JT; Fehlings MG
    Exp Neurol; 2012 May; 235(1):78-90. PubMed ID: 21333647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection and Repair After Spinal Cord Injury: Accomplishments and Future Directions.
    Dietrich WD
    Top Spinal Cord Inj Rehabil; 2015; 21(2):174-87. PubMed ID: 26364287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stem cell therapy in spinal cord injuries: current concepts.
    Chhabra HS
    J Assoc Physicians India; 2012 May; 60 Suppl():30-3. PubMed ID: 23155794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regeneration of descending axon tracts after spinal cord injury.
    Deumens R; Koopmans GC; Joosten EA
    Prog Neurobiol; 2005; 77(1-2):57-89. PubMed ID: 16271433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on the treatment of spinal cord injury.
    Baptiste DC; Fehlings MG
    Prog Brain Res; 2007; 161():217-33. PubMed ID: 17618980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An appraisal of ongoing experimental procedures in human spinal cord injury.
    Amador MJ; Guest JD
    J Neurol Phys Ther; 2005 Jun; 29(2):70-86. PubMed ID: 16386164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spinal cord injury: overview of experimental approaches used to restore locomotor activity.
    Fakhoury M
    Rev Neurosci; 2015; 26(4):397-405. PubMed ID: 25870961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological approaches to repair the injured spinal cord.
    Baptiste DC; Fehlings MG
    J Neurotrauma; 2006; 23(3-4):318-34. PubMed ID: 16629619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The rocky road to translation in spinal cord repair.
    Filli L; Schwab ME
    Ann Neurol; 2012 Oct; 72(4):491-501. PubMed ID: 23109144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of the behavioral and anatomical outcomes in sub-acute and chronic spinal cord injury models following treatment with human mesenchymal precursor cell transplantation and recombinant decorin.
    Hodgetts SI; Simmons PJ; Plant GW
    Exp Neurol; 2013 Oct; 248():343-59. PubMed ID: 23867131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimization of the decision-making process for the selection of therapeutics to undergo clinical testing for spinal cord injury in the North American Clinical Trials Network.
    Guest J; Harrop JS; Aarabi B; Grossman RG; Fawcett JW; Fehlings MG; Tator CH
    J Neurosurg Spine; 2012 Sep; 17(1 Suppl):94-101. PubMed ID: 22985376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current status of experimental cell replacement approaches to spinal cord injury.
    Eftekharpour E; Karimi-Abdolrezaee S; Fehlings MG
    Neurosurg Focus; 2008; 24(3-4):E19. PubMed ID: 18341395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Providing the clinical basis for new interventional therapies: refined diagnosis and assessment of recovery after spinal cord injury.
    Curt A; Schwab ME; Dietz V
    Spinal Cord; 2004 Jan; 42(1):1-6. PubMed ID: 14713937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intervention strategies to enhance anatomical plasticity and recovery of function after spinal cord injury.
    Bregman BS; Diener PS; McAtee M; Dai HN; James C
    Adv Neurol; 1997; 72():257-75. PubMed ID: 8993704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Demonstrating efficacy in preclinical studies of cellular therapies for spinal cord injury - how much is enough?
    Kwon BK; Soril LJ; Bacon M; Beattie MS; Blesch A; Bresnahan JC; Bunge MB; Dunlop SA; Fehlings MG; Ferguson AR; Hill CE; Karimi-Abdolrezaee S; Lu P; McDonald JW; Müller HW; Oudega M; Rosenzweig ES; Reier PJ; Silver J; Sykova E; Xu XM; Guest JD; Tetzlaff W
    Exp Neurol; 2013 Oct; 248():30-44. PubMed ID: 23727091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perspectives on tissue-engineered nerve regeneration for the treatment of spinal cord injury.
    Kim MS; Lee HB
    Tissue Eng Part A; 2014 Jul; 20(13-14):1781-3. PubMed ID: 24568624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bench to bedside: challenges of clinical translation.
    Steeves JD
    Prog Brain Res; 2015; 218():227-39. PubMed ID: 25890140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical relevance of gait research applied to clinical trials in spinal cord injury.
    Ditunno J; Scivoletto G
    Brain Res Bull; 2009 Jan; 78(1):35-42. PubMed ID: 18848865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility of patient recruitment into clinical trials of experimental treatments for acute spinal cord injury.
    Lee RS; Noonan VK; Batke J; Ghag A; Paquette SJ; Boyd MC; Fisher CG; Street J; Dvorak MF; Kwon BK
    J Clin Neurosci; 2012 Oct; 19(10):1338-43. PubMed ID: 22921530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.